No category found.

  • To immediately adopt the new therapy.
  • To urgently advise that conclusions should not be based on a single study, especially close to the significance threshold, and that replication and meta-analysis are critically important.
  • To ignore all p-values.
  • To assume one study is enough.
  • To immediately abandon the therapy.
  • To urgently consider the implications of low power (high risk of Type II error) and the need for a larger, adequately powered trial before discarding a potentially beneficial therapy.
  • To fund a smaller, less expensive trial.
  • To rely solely on the current non-significant p-value.
Scroll to Top